Matches in Nanopublications for { ?s ?p "[These results may provide a basis of developing improved chemotherapy regimens, including or excluding glucocorticoid receptor agonists/antagonists, for urothelial carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- NP692034.RARzTGFAfIRCDgpWE7iVAFGQlTYVz-1DMOhpByz0bd16M130_assertion description "[These results may provide a basis of developing improved chemotherapy regimens, including or excluding glucocorticoid receptor agonists/antagonists, for urothelial carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP692034.RARzTGFAfIRCDgpWE7iVAFGQlTYVz-1DMOhpByz0bd16M130_provenance.
- assertion description "[These results may provide a basis of developing improved chemotherapy regimens, including or excluding glucocorticoid receptor agonists/antagonists, for urothelial carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[These results may provide a basis of developing improved chemotherapy regimens, including or excluding glucocorticoid receptor agonists/antagonists, for urothelial carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1017859.RAU03l64t-RewlJ397QfY_iI4gGLGYQJYxSmf-uyXjH-k130_assertion description "[These results may provide a basis of developing improved chemotherapy regimens, including or excluding glucocorticoid receptor agonists/antagonists, for urothelial carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1017859.RAU03l64t-RewlJ397QfY_iI4gGLGYQJYxSmf-uyXjH-k130_provenance.
- NP435425.RAgSw0wNRA_2wO2dkZuFgl2ZBSSxuiaEGSYvaQsGGmXaM130_assertion description "[These results may provide a basis of developing improved chemotherapy regimens, including or excluding glucocorticoid receptor agonists/antagonists, for urothelial carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP435425.RAgSw0wNRA_2wO2dkZuFgl2ZBSSxuiaEGSYvaQsGGmXaM130_provenance.
- NP434790.RAKyavHihP0bgqtUQRAZg-hxwUMf8Qi0Sv7dQlz-77h7s130_assertion description "[These results may provide a basis of developing improved chemotherapy regimens, including or excluding glucocorticoid receptor agonists/antagonists, for urothelial carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP434790.RAKyavHihP0bgqtUQRAZg-hxwUMf8Qi0Sv7dQlz-77h7s130_provenance.
- NP1017861.RA48XBot1Ggq9WAivC0ly6oOwloDUyc4IOQJPdrmw0lFw130_assertion description "[These results may provide a basis of developing improved chemotherapy regimens, including or excluding glucocorticoid receptor agonists/antagonists, for urothelial carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1017861.RA48XBot1Ggq9WAivC0ly6oOwloDUyc4IOQJPdrmw0lFw130_provenance.